Home › Drug Codes › J Codes › J0750 · TRUVADA
Updated October 1st, 2026

TRUVADA J Code: J0750

Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

Login to unlock all benchmarks
Medicare Payment Limit ?
$0.451
/ HCPCS billing unit
APC Payment Limit ?
$0.451
/ HCPCS billing unit · APC 0806
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
22
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
HCPCS Added Date January 2, 2024
Manufacturer Multiple Manufacturers
Route of Administration Oral
Generic Status Multi-Source; Generic
Dosage Form Tablet | Tablet, Film Coated

About TRUVADA

Truvada is a medication aligned to the HCPCS J Code: J0750 for billing, pricing, and reimbursement purposes in the United States. This Anti-HIV medication is administered via the oral route and manufactured by multiple companies.

According to CMS Drug Use Information: This product is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Combination treatment with at least one other HIV medication should be used. This product is also used to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

22 NDC packages are crosswalked to J0750. Package detail is available to logged-in subscribers.

Login to view 22 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

TRUVADA Pricing & Reimbursement

J0750 Private Payer Reimbursement
$1.35 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

TRUVADA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Treatment of HIV-1 Infection HIV-1 Pre-Exposure Prophylaxis (PrEP)
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Reverse Transcriptase Inhibitors [MoA]Nucleosides [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Truvada billing and coding guide?
We have not yet identified a manufacturer source of Truvada billing and coding information.
Are there any available Truvada patient assistance programs?
Our team did not identify a source for Truvada patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Truvada prescribing information?
TRUVADA prescribing information can be found at the link below: Visit Here →
Where can I find Truvada side effect information?
Information regarding TRUVADA's side effects can be found at MedlinePlus Visit Here →
Does billing TRUVADA require JZ/JW wastage modifiers?
CMS does not include TRUVADA (J0750) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0750. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.